Attention-deficit hyperactivity disorder (Q92940629)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31982036 AND SRC:MED&resulttype=core&format=json

2 May 2020

review article

1 reference

title

Attention-deficit hyperactivity disorder (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31982036 AND SRC:MED&resulttype=core&format=json

attention deficit hyperactivity disorder

2 May 2020

main subject

1 reference

inferred from title

author

Guilherme V Polanczyk

series ordinal

2

object named as

Guilherme V Polanczyk

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31982036 AND SRC:MED&resulttype=core&format=json

2 May 2020

3

Edmund Sonuga-Barke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31982036 AND SRC:MED&resulttype=core&format=json

2 May 2020

author name string

Jonathan Posner

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31982036 AND SRC:MED&resulttype=core&format=json

2 May 2020

publication date

23 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31982036 AND SRC:MED&resulttype=core&format=json

2 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31982036 AND SRC:MED&resulttype=core&format=json

2 May 2020

volume

395

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31982036 AND SRC:MED&resulttype=core&format=json

2 May 2020

issue

10222

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31982036 AND SRC:MED&resulttype=core&format=json

2 May 2020

page(s)

450-462

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31982036 AND SRC:MED&resulttype=core&format=json

Psychiatric genetics and the structure of psychopathology.

2 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Annual research review: categories versus dimensions in the classification and conceptualisation of child and adolescent mental disorders--implications of recent empirical study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Moving towards causality in attention-deficit hyperactivity disorder: overview of neural and genetic mechanisms

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

The global market for ADHD medications.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

The MTA at 8 Years: Prospective Follow-up of Children Treated for Combined-Type ADHD in a Multisite Study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Risks and Benefits of Attention-Deficit/Hyperactivity Disorder Medication on Behavioral and Neuropsychiatric Outcomes: A Qualitative Review of Pharmacoepidemiology Studies Using Linked Prescription Databases

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Review of medication adherence in children and adults with ADHD.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Barriers to detection, help-seeking, and service use for children with ADHD symptoms

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Instability of the DSM-IV Subtypes of ADHD from preschool through elementary school

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Innovations and changes in the ICD-11 classification of mental, behavioural and neurodevelopmental disorders

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Is Adult ADHD a Childhood-Onset Neurodevelopmental Disorder? Evidence From a Four-Decade Longitudinal Cohort Study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Late-Onset ADHD Reconsidered With Comprehensive Repeated Assessments Between Ages 10 and 25.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

ADHD Symptoms in a Non-Referred Low Birthweight/Preterm Cohort: Longitudinal Profiles, Outcomes, and Associated Features

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

A risk calculator to predict adult attention-deficit/hyperactivity disorder: generation and external validation in three birth cohorts and one clinical sample

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Annual research review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

The worldwide prevalence of ADHD: a systematic review and metaregression analysis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Annual research review: Secular trends in child and adolescent mental health.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Is ADHD Really Increasing in Youth?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Has the attention deficit hyperactivity disorder phenotype become more common in children between 2004 and 2014? Trends over 10 years from a Swedish general population sample

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Annual Research Review: Does late-onset attention-deficit/hyperactivity disorder exist?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Practitioner Review: Pathways to care for ADHD - a systematic review of barriers and facilitators

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: a meta-regression analysis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Trajectories of Growth Associated With Long-Term Stimulant Medication in the Multimodal Treatment Study of Attention-Deficit/Hyperactivity Disorder

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Methylphenidate and growth in hyperactive children. A controlled withdrawal study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Drug Holidays From ADHD Medication: International Experience Over the Past Four Decades.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Stimulant ADHD medication and risk for substance abuse

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Stimulant prescription cautions: addressing misuse, diversion and malingering

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

ADHD drugs and serious cardiovascular events in children and young adults

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

ADHD medications and risk of serious cardiovascular events in young and middle-aged adults.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Efficacy and safety of atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: results from a comprehensive meta-analysis and metaregression

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

A Randomized, Placebo-Controlled Trial of Guanfacine Extended Release in Adolescents With Attention-Deficit/Hyperactivity Disorder

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Enhancing ADHD medication adherence: challenges and opportunities

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Psychopharmacology of ADHD in pediatrics: current advances and issues

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Does methylphenidate improve academic performance? A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Modifiers of long-term school outcomes for children with attention-deficit/hyperactivity disorder: does treatment with stimulant medication make a difference? Results from a population-based study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Medication for attention deficit-hyperactivity disorder and criminality

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Association Between Medication Use for Attention-Deficit/Hyperactivity Disorder and Risk of Motor Vehicle Crashes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Attention-deficit hyperactivity disorder, its treatment with medication and the probability of developing a depressive disorder: A nationwide population-based study in Taiwan.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Fasoracetam in adolescents with ADHD and glutamatergic gene network variants disrupting mGluR neurotransmitter signaling.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Paying attention to acetylcholine: the key to wisdom and quality of life?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Effects of acute nicotine administration on behavioral inhibition in adolescents with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

A pilot controlled trial of transdermal nicotine in the treatment of attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Short- and Long-Term Effects of Parent Training for Preschool Children With or at Risk of ADHD: A Systematic Review and Meta-Analysis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Neurofeedback for Attention-Deficit/Hyperactivity Disorder: Meta-Analysis of Clinical and Neuropsychological Outcomes From Randomized Controlled Trials

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Cognitive training for attention-deficit/hyperactivity disorder: meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Cogmed Working Memory Training for youth with ADHD: a closer examination of efficacy utilizing evidence-based criteria.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Computerized training of working memory in children with ADHD--a randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Research review: the role of diet in the treatment of attention-deficit/hyperactivity disorder--an appraisal of the evidence on efficacy and recommendations on the design of future studies

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Exercise: applications to childhood ADHD.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Multimodal treatment in children and adolescents with attention-deficit/hyperactivity disorder: a 6-month follow-up.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Molecular genetics of attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

The relative contribution of common and rare genetic variants to ADHD

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Discoveries on the Genetics of ADHD in the 21st Century: New Findings and Their Implications

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Low blood lead levels associated with clinically diagnosed attention-deficit/hyperactivity disorder and mediated by weak cognitive control

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Prenatal smoking exposure, low birth weight, and disruptive behavior disorders

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Fetal growth and psychiatric and socioeconomic problems: population-based sibling comparison

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Contributions of parental alcoholism, prenatal substance exposure, and genetic transmission to child ADHD risk: a female twin study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: a randomised, double-blinded, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Variation in an Iron Metabolism Gene Moderates the Association Between Blood Lead Levels and Attention-Deficit/Hyperactivity Disorder in Children

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Biological and rearing mother influences on child ADHD symptoms: revisiting the developmental interface between nature and nurture

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Early severe institutional deprivation is associated with a persistent variant of adult attention-deficit/hyperactivity disorder: clinical presentation, developmental continuities and life circumstances in the English and Romanian Adoptees study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Shared genetic factors, fetal programming, and the transmission of depression

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Measured Gene-by-Environment Interaction in Relation to Attention-Deficit/Hyperactivity Disorder

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Epigenetic profiling of ADHD symptoms trajectories: a prospective, methylome-wide study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Annual Research Review: DNA methylation as a mediator in the association between risk exposure and child and adolescent psychopathology

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Co-occurrence of ADHD and low IQ has genetic origins.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Dissociable attentional and affective circuits in medication-naïve children with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Causal Heterogeneity in Attention-Deficit/Hyperactivity Disorder: Do We Need Neuropsychologically Impaired Subtypes?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Characterizing cognition in ADHD: beyond executive dysfunction

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Persistent neuropsychological deficit in euthymic bipolar patients: executive function as a core deficit.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Neurodevelopment and executive function in autism

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Is hyperactivity ubiquitous in ADHD or dependent on environmental demands? Evidence from meta-analysis.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Time reproduction in children with ADHD: motivation matters

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

The cognitive-energetic model: an empirical approach to attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Psychological heterogeneity in AD/HD--a dual pathway model of behaviour and cognition

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Modifiable Arousal in Attention-Deficit/Hyperactivity Disorder and Its Etiological Association With Fluctuating Reaction Times

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Brain arousal regulation in adults with attention-deficit/hyperactivity disorder (ADHD).

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

A meta-analytic study of event rate effects on Go/No-Go performance in attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Quantitative Brain Magnetic Resonance Imaging in Attention-Deficit Hyperactivity Disorder

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Connecting the dots: a review of resting connectivity MRI studies in attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Atypical default network connectivity in youth with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Spontaneous attentional fluctuations in impaired states and pathological conditions: a neurobiological hypothesis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Neural Correlates of Aggression in Medication-Naive Children with ADHD: Multivariate Analysis of Morphometry and Tractography

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: a cross-sectional mega-analysis.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Ventral-striatal responsiveness during reward anticipation in ADHD and its relation to trait impulsivity in the healthy population: a meta-analytic review of the fMRI literature

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Disturbed structural connectivity is related to inattention and impulsivity in adult attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

The association between antidepressant treatment and brain connectivity in two double-blind, placebo-controlled clinical trials: a treatment mechanism study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

DSM-V and the future diagnosis of attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

The Role of Precision Medicine in Child Psychiatry: What Can We Expect and When?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Preventive Interventions for ADHD: A Neurodevelopmental Perspective

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Preschool hyperactivity specifically elevates long-term mental health risks more strongly in males than females: a prospective longitudinal study through to young adulthood.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Attention training for infants at familial risk of ADHD (INTERSTAARS): study protocol for a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Practitioner Review: Current best practice in the use of parent training and other behavioural interventions in the treatment of children and adolescents with attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

A neurodevelopmental perspective on the research domain criteria (RDoC) framework

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Annual research review: Infant development, autism, and ADHD--early pathways to emerging disorders

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Exposure to gestational diabetes mellitus and low socioeconomic status: effects on neurocognitive development and risk of attention-deficit/hyperactivity disorder in offspring

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Enhanced sensitivity to drugs of abuse and palatable foods following maternal overnutrition

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Maternal obesity and neurodevelopmental and psychiatric disorders in offspring.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Neuromodulation in Tourette syndrome: dopamine and beyond

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021

Sudden death and use of stimulant medications in youths.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(19)33004-1

7 January 2021